Top

Osteoporosis International

Published in:

01-07-2006 | Original Article

Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency

Authors: O. Sahota, M. K. Mundey, P. San, I. M. Godber, D. J. Hosking

Published in: Osteoporosis International | Issue 7/2006

Abstract

Introduction

Vitamin D insufficiency is common, however within individuals, not all manifest the biochemical effects of PTH excess. This further extends to patients with established osteoporosis. The mechanism underlying the blunted PTH response is unclear but may be related to magnesium (Mg) deficiency. The aims of this study were to compare in patients with established osteoporosis and differing degrees of vitamin D and PTH status : (1) the presence of Mg deficiency using the standard Mg loading test (2) evaluate the effects of Mg loading on the calcium-PTH endocrine axis (3) determine the effects of oral, short term Mg supplementation on the calcium-PTH endocrine axis and bone turnover.

Methods

30 patients (10 women in 3 groups) were evaluated prospectively measuring calcium, PTH, Mg retention (Mg loading test), dietary nutrient intake (calcium, vitamin D, Mg) and bone turnover markers (serum CTX & P1CP). Multivariate analysis controlling for potential confounding baseline variable was undertaken for the measured outcomes.

Results

All subjects, within the low vitamin D and low PTH group following the magnesium loading test had evidence of Mg depletion [mean(SD) retention 70.3%(12.5)] and showed an increase in calcium 0.06(0.01) mmol/l [95% CI 0.03, 0.09, p=0.007], together with a rise in PTH 13.3 ng/l (4.5) [95% CI 3.2, 23.4, p=0.016] compared to baseline. Following oral supplementation bone turnover increased: CTX 0.16 (0.06) mcg/l [95%CI 0.01, 0.32 p=0.047]; P1CP 13.1 (5.7) mcg/l [95% CI 0.29, 26.6 p=0.049]. In subjects with a low vitamin D and raised PTH mean retention was 55.9%(14.8) and in the vitamin replete group 36.1%(14.4), with little change in both acute markers of calcium homeostasis and bone turnover markers following both the loading test and oral supplementation.

Conclusions

This study confirms that in patients with established osteoporosis, there is also a distinct group with a low vitamin D and a blunted PTH level and that Mg deficiency (as measured by the Mg loading test) is an important contributing factor.

Guillemant J, Taupin P, Le HT, Taright N, Allemanandou A, Pérès G, Guillemant S (1999) Vitamin D status during puberty in French health male adolescents. Osteop Int 10:222–225CrossRef

Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hereberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteop Int 7:439–443CrossRef

Melin AL, Wilske J, Ringertz H, Sääf M (2000) Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging Clin Exp Res 11:200–207

Serhan E, Newton P, Ali HA, Walford S, Singh BM (1999) Prevalence of hypovitaminosis D in Indo-Asian patients attending a rheumatology clinic. Bone 5:609–611CrossRef

Bettica P, Bevilacqua M, Vago T, Norbiato (1999) High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in Northern Italy for initial screening. Osteop Int 9:226–229CrossRef

Aguado P, del Campo MT, Garcés MV, González-Casaús ML, Bernad M, Gijón-Baños J et al (2000) Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteop Int 11:739–744CrossRef

Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD (1982) Vitamin D and bone health. Am J Clin Nutr 36:1014–1031PubMed

Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson Hughes B (1989) Effect of vitamin D intake on seasonal variation in parathyroid hormone secretion in post menopausal women. N Eng J Med 321:1777–1783CrossRef

Gloth III MF, Gundberg CM, Hollis BW, Haddad Jr JG, Tobin JD (1995) Vitamin D deficiency in homebound elderly persons. JAMA 274:1683–1686CrossRefPubMed

10.

Malabanan A, Veronikis IE, Holick FM (1998) Refining vitamin D insufficiency. Lancet 351:805–806CrossRefPubMed

11.

Sahota O, Masud T, San P, Hosking DJ (1999) Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hips in patients with established osteoporosis. Clin Endocrinol 51:217–221CrossRef

12.

Lamberg-Allardt C, von Knorring J, Slatis P, Holmstrom T (1988) Vitamin D status and concentrations of serum vitamin D metabolites and osteocalcin in elderly patients with femoral neck fracture: a follow-up study. Eur J Clin Nutr 43:355–361

13.

LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J (1999) Occult vitamin D deficiency in post menopausal US women with acute hip fracture. JAMA 281:1505–1511PubMedCrossRef

14.

Rao DS Perspective on assessment of vitamin D nutrition (1999) J Clin Densitometry 2:457–464CrossRef

15.

Rao DS, Kleerekoper M, Rogers M, Frame B, Parfitt A (1984) Is gastrectomy a risk factor for osteoporosis? In: Christiansen C (ed) Osteoporosis. Glostrup Hospital, Denmark 775–777

16.

Parfitt AM, Podenphant J, Villanueva AR, Frame B (1985) Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 6:211–220CrossRefPubMed

17.

Sahota O, Gaynor K, Harwood RH, Hosking DJ (2001) Hypovitaminosis D and functional hypoparathyroidism. The NoNOF (Nottingham Neck of Femur) Study. Age Ageing 6:467–472CrossRef

18.

Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D & parathyroid hormone: Calcium homeostasis, bone turnover and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312–319CrossRefPubMed

19.

Rude RK, Oldham SB, Singer FR (1986) Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human Mg deficiency. Clin Endocrinol 5:209–224

20.

Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14–20PubMedCrossRef

21.

Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef

22.

Ryzen E, Elbaum N, Singer FR, Rude RK (1985) Parental Mg tolerance testing in the evaluation of Mg deficiency. Magnesium 4:137–147PubMed

23.

Rude RK, Bethune JE, Singer FR (1980) Renal tubular maximum for magnesium in normal, hyperparathyroid and hypoparathyroid man. J Clin Endocrinol Metab 51:1425–1431PubMed

24.

Cohen L, Laor A, Kitzes R (1983) Magnesium malabsorption in postmenopausal osteoporosis. Magnesium 2:271–274

25.

Reginster JY, Strause L, Deroisy R, Lecart MP, Saltman P, Franchimont P (1989) Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium 8:106–109PubMed

26.

Siener R, Hesse A (1995) Influence of a mixed and a vegetarian diet on urinary Mg excretion and concentration. B J Nutr 54:553–559

27.

Rude RK, Olerich K (1996) Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteop Int 6:453–461CrossRef

28.

Anast CS, Winnacker JL, Forte LR, Burns TW (1986) Impaired release of parathyroid hormone in Mg deficiency. J Clin Endocrinol Metab 42:707–717CrossRef

29.

Zajac JD (2000) Regulation of parathyroid function. Bone 27:7SCrossRef

30.

Eskiyurt N, Akt S, Aydogan A, Aksac B, Sen N, Akyuz G, Oncel A (2000) The evaluation of the effects of calcium, magnesium and vitamin D derivatives on bone density and biochemical markers of bone turnover in cases of postmenopausal osteoporosis. Osteop Int 3(S62):23

31.

Rude RK, Oldham SB, Sharp CF Jr, Singer FR (1978) Parathyroid hormone secretion in Mg deficiency. J Clin Endo Metab 47:800–806

32.

Medalle R, Waterhouse C, Hahn TJ (1986) Vitamin D resistance in Mg deficiency. Am J Clin Nutr 29:854–858

33.

Bjarnasson HN, Christiansen C (2000) Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 26:561–569CrossRefPubMed

34.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas (2000) PD Biochemical makers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women. J Bone Miner Res 15:1526–1536PubMedCrossRef

Title: Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency
Authors: O. Sahota
M. K. Mundey
P. San
I. M. Godber
D. J. Hosking
Publication date: 01-07-2006
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 7/2006
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-006-0084-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2006

Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations

Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture

Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women

Dancing for bone health: a 3-year longitudinal study of bone mineral accrual across puberty in female non-elite dancers and controls

Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves’ disease

Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists